Bayer HealthCare and Regeneron to Collaborate on VEGF Trap for the Treatment of Eye Diseases Regeneron Retains U.S. Commercialization Rights, Receives
Wednesday, October 18, 2006 1 min read
Key Takeaway: Bayer HealthCare and Regeneron to Collaborate on VEGF Trap for the Treatment of Eye Diseases Regeneron Retains U.S. Commercialization Rights, Receives
Full Press Release Details
Bayer HealthCare and Regeneron to Collaborate on VEGF Trap for the Treatment of Eye Diseases Regeneron Retains U.S. Commercialization Rights, Receives.